All right, okay. We'll get started here. I'm Eric Joseph, Senior Biotech Analyst with JPMorgan. And our next presenting company is Novavax. Presenting on behalf of the company is CEO, John Jacobs.

The vaccine maker's shares plunged Wednesday as 2023 results and its 2024 revenue forecast disappointed investors. Novavax to pay millions in settlement with vaccine nonprofit Emergent BioSolutions ...

Novavax Inc NVAX reported Q3 revenue of $187 million, compared to $735 million in the same period in 2022, beating the consensus of $158.54 million. "We've really optimized that U.S. grant opportunity ...

Gaithersburg, Maryland-based COVID-19 vaccine maker Novavax, which announced a restructuring this summer that included cutting its workforce by 25%, saw its third quarter revenue tumble and it plans ...

Novavax isn’t in a good financial position to be refunding money to customers, having gone through a cost-saving restructuring amid flagging sales of the Covid-19 vaccine that is its only ...

Stream Connecticut News for free, 24/7, wherever you are. Shares of Novavax closed nearly 100% higher on Friday from their previous day close of $4.47 apiece. The licensing agreement will allow ...

Shares of Novavax closed nearly 50% higher on Monday as Wall Street cheered the company's new multibillion-dollar deal with French drugmaker Sanofi that sparked a dramatic turnaround for the ...

Novavax stock (NVAX) skyrocketed on Friday, nearly doubling on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in a deal for Novavax's COVID-19 vaccine and take a ...

Pharmaceutical giant Novavax on Monday announced that the U.S. Food and Drug Administration (FDA) approved its COVID-19 vaccine, Nuvaxovid. Novavax’s shares traded nearly 20% in pre-market trading at ...

(Reuters) -A top shareholder of COVID-19 vaccine maker Novavax on Monday said the company has been badly mismanaged and nominated two candidates to serve on Novavax's board. Shah Capital, which owns a ...

Novavax delayed its timeline for ramping up the company's COVID-19 vaccine production until the latter half of 2021. Novavax President and CEO Stanley Erck joins Yahoo Finance Live to discuss. JULIE ...

Don’t call it a comeback: Novavax just (briefly) became a meme stock. The Maryland-based biotech joined the likes of Ango American, Vodafone and the notorious GameStop in a resurgence of the meme ...